TRIPS and Essential Medicines: Must One Size Fit All? Making the WTO Responsive to the Global Health Crisis
INCENTIVES FOR GLOBAL HEALTH: PATENT LAW AND ACCESS TO ESSENTIAL MEDICINES, Thomas Pogge, Matthew Rimmer, Kim Rubenstein, eds. Cambridge University Press, 2010
29 Pages Posted: 5 Aug 2009 Last revised: 21 Aug 2009
Date Written: August 3, 2009
Abstract
This paper was written as the introductory chapter to Incentives for Global Health: Patent Law and Access to Essential Medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein (Cambridge University Press). It challenges the critique of the TRIPS Agreement as a one-size-fits-all regime. To be sure, there are WTO members who prefer to think of the Agreement that way. However, the paper demonstrates how the flexibilities built into the TRIPS Agreement allow a state to fashion local law to deal with its population’s health needs. TRIPS accommodations are not perfect: the second part of the paper considers the roles that other international organizations, such as WHO, and other international obligations, such as human rights agreements, can be used to influence the development and interpretation of international intellectual property law.
Keywords: international intellectual property law, health, intellectual property law, TRIPS Agreement
JEL Classification: I1, K32, K33, O34
Suggested Citation: Suggested Citation
Do you have a job opening that you would like to promote on SSRN?
Recommended Papers
-
Raising Human Rights Arguments in WTO Dispute Settlement Proceedings
-
Cornering the Market in a Post-9/11 World: The Future of Horizontal Restraints
-
Biopiracy and Beyond: A Consideration of Socio-Cultural Conflicts with Global Patent Policies
-
The Problem with Congress and Copyright Law: Forgetting the Past and Ignoring the Public Interest
-
Patent Breaking or Balancing? Separating Strands of Fact from Fiction Under TRIPS
-
Patent Rights and Human Rights: Exploring Their Relationships